Facebook
X
LinkedIn
ForwardThis Will Take Your Breath Away: 2025 GOLD COPD Guidelines Updates
The presentation will explore the relationship between COPD and cardiovascular risk, highlighting the frequent coexistence of these conditions and their impact on patient outcomes. It will also examine the role of new agents, ensifentrine and dupilumab, in COPD management and where they fit into patient care. Lastly, the discussion will cover the latest vaccination recommendations for this specific patient population.
Target Audience
Pharmacist
Learning Objectives
At the conclusion of this activity, participants should be able to:
Describe the pathophysiology and current therapies approved for COPD
Discuss the current and new treatment options available for the management of COPD
Utilize updated guideline recommendations to optimize treatment decisions in clinical practice
The presentation will explore the relationship between COPD and cardiovascular risk, highlighting the frequent coexistence of these conditions and their impact on patient outcomes. It will also examine the role of new agents, ensifentrine and dupilumab, in COPD management and where they fit into patient care. Lastly, the discussion will cover the latest vaccination recommendations for this specific patient population.
Diamond Orji, PharmD PGY1 Pharmacy Resident
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 0.5 contact hours of continuing pharmacy education credit.
Available Credit
- 0.50 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.